These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 7844688

  • 1. Infectious hazards of immune globulin.
    Barton LL.
    J Pediatr; 1995 Feb; 126(2):321-2. PubMed ID: 7844688
    [No Abstract] [Full Text] [Related]

  • 2. The safety of immune globulins.
    Tepper M, Gully P.
    Can Commun Dis Rep; 1996 Jul 15; 22(14):117-9. PubMed ID: 8754937
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hepatitis C and immune globulin.
    Douglas SD, Slade HB.
    N Engl J Med; 1995 May 04; 332(18):1235; author reply 1236-7. PubMed ID: 7700323
    [No Abstract] [Full Text] [Related]

  • 5. Hepatitis C and immune globulin.
    López-Jiménez J, Odriozola J, Pérez-Oteyza J, García-Laraña J.
    N Engl J Med; 1995 May 04; 332(18):1235-6. PubMed ID: 7700324
    [No Abstract] [Full Text] [Related]

  • 6. Hepatitis C and immune globulin.
    Prince AM, Horowitz B.
    N Engl J Med; 1995 May 04; 332(18):1236; author reply 1236-7. PubMed ID: 7700325
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Transmission of hepatitis after the administration of intravenous immunoglobulins.
    Rousell RH, Dobkin MB, Budinger MD, Louie RE.
    Am J Clin Pathol; 1993 May 04; 99(5):649. PubMed ID: 8493958
    [No Abstract] [Full Text] [Related]

  • 9. Hepatitis C transmission associated with intravenous immunoglobulins.
    Yu MW, Mason BL, Guo ZP, Tankersley DL, Nedjar S, Mitchell FD, Biswas RM.
    Lancet; 1995 May 06; 345(8958):1173-4. PubMed ID: 7536874
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hepatitis C from immunoglobin infusions.
    Lehner PS, Webster AD.
    BMJ; 1993 Jun 05; 306(6891):1541-2. PubMed ID: 8518699
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin.
    Bjøro K, Frøland SS, Yun Z, Samdal HH, Haaland T.
    N Engl J Med; 1994 Dec 15; 331(24):1607-11. PubMed ID: 7526215
    [Abstract] [Full Text] [Related]

  • 15. 111 cases of hepatitis C linked to Gammagard. Patient screening recommended.
    Am J Hosp Pharm; 1994 Oct 01; 51(19):2326. PubMed ID: 7847397
    [No Abstract] [Full Text] [Related]

  • 16. Side-effects of intravenous immune globulins.
    Duhem C, Dicato MA, Ries F.
    Clin Exp Immunol; 1994 Jul 01; 97 Suppl 1(Suppl 1):79-83. PubMed ID: 8033440
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis C virus transmission by intravenous immunoglobulin.
    Farrugia A, Walker E.
    Lancet; 1995 Aug 05; 346(8971):373; author reply 374-5. PubMed ID: 7542718
    [No Abstract] [Full Text] [Related]

  • 18. Hepatitis C virus transmission by intravenous immunoglobulin.
    James RC, Mosley JW.
    Lancet; 1995 Aug 05; 346(8971):374; author reply 374-5. PubMed ID: 7542719
    [No Abstract] [Full Text] [Related]

  • 19. HCV and Gammagard in France.
    Gomperts ED.
    Lancet; 1994 Jul 16; 344(8916):201. PubMed ID: 7912801
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.